EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis

Simon Skurkovich, Galina Lukina, Yakov Sigidin, Olga Pushkova, Evelyna Mach, Boris Skurkovich

Journal of Immune Based Therapies, Vaccines and Antimicrobials · 2015

DOI: 10.4236/jibtva.2015.41001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immune Based Therapies, Vaccines and Antimicrobials, 2015. Verfasst von Simon Skurkovich und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 1974, in Nature, one of us has proposed a radically new idea that led to the development of anticytokine therapy which is now used around the world for the treatment of autoimmune diseases. We were the first to use antibodies to IFN-γ and were some of the first to suggest using antagonists of TNF-α in the treatment of autoimmune and inflammatory diseases as well. Our method suppresses one of the main pathogenetic mechanisms of these diseases. Antibodies to IFN-γ and TNF-α exhibit dramatic effects on clinical manifestations of rheumatoid arthritis (RA). However, in our trial ultrasound assessment of the synovial membrane thickness in RA patients showed that only anti-IFN-γ exerted pronounced anti-inflammatory effect. Some patients who underwent treatment with antibodies to TNF-α developed a number of complications. Anticytokine therapy (mono- and poly-) alone or in combination with other drugs can possibly be used not only in the treatment of autoimmune diseases, but also in other pathologies with cytokine synthesis disturbances (a number of neurological, psychiatric, endocrine, and other diseases).

Zitieren

APA

Skurkovich, S., Lukina, G., Sigidin, Y., Pushkova, O., Mach, E., & Skurkovich, B. (2015). Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis. Journal of Immune Based Therapies, Vaccines and Antimicrobials. https://doi.org/10.4236/jibtva.2015.41001

Vancouver

Skurkovich S, Lukina G, Sigidin Y, Pushkova O, Mach E, Skurkovich B. Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis. Journal of Immune Based Therapies, Vaccines and Antimicrobials. 2015. doi:10.4236/jibtva.2015.41001

BibTeX
@article{Skurkovich2015,
  author = {Skurkovich, Simon and Lukina, Galina and Sigidin, Yakov and Pushkova, Olga and Mach, Evelyna and Skurkovich, Boris},
  title = {Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis},
  journal = {Journal of Immune Based Therapies, Vaccines and Antimicrobials},
  year = {2015},
  doi = {10.4236/jibtva.2015.41001}
}
Kostenlos starten →